Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 92

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Assessment of liver fibrosis with transient elastography and FibroTest in patients treated with methotrexate for chronic inflammatory diseases: A case–control study

Laharie, David, Seneschal, Julien, Schaeverbeke, Thierry, Doutre, Marie-Sylvie, Longy-Boursier, Maïté, Pellegrin, Jean-Luc, Chabrun, Edouard, Villars, Sandrine, Zerbib, Frank, de Lédinghen, Victor · 2010 · Journal of Hepatology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2010.04.043

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 44

  1. Kremer, 1986, The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis, Arthritis Rheum, 29, 822, 10.1002/art.1780290702 · DOI · Paper page
  2. Laharie, 2008, The liver and methotrexate, Gastroenterol Clin Biol, 32, 134, 10.1016/j.gcb.2007.11.002 · doi:10.1016/j.gcb.2007.11.002
  3. Lanse, 1985, Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio, Dig Dis Sci, 30, 104, 10.1007/BF01308193 · doi:10.1007/bf01308193
  4. Te, 2000, Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease, Am J Gastroenterol, 95, 3150, 10.1111/j.1572-0241.2000.03287.x · doi:10.1111/j.1572-0241.2000.03287.x
  5. Kremer, 1994, Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology, Arthritis Rheum, 37, 316, 10.1002/art.1780370304 · DOI · Paper page
  6. Chande, 2005, A survey of Canadian gastroenterologists about the use of methotrexate in patients with Crohn’s disease, Can J Gastroenterol, 19, 553, 10.1155/2005/382379 · doi:10.1155/2005/382379
  7. Kalb, 2009, Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference, J Am Acad Dermatol, 60, 824, 10.1016/j.jaad.2008.11.906 · DOI · Paper page
  8. Cadranel, 2000, Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF), Hepatology, 32, 477, 10.1053/jhep.2000.16602 · DOI · Paper page
  9. Bravo, 2001, Liver biopsy, N Engl J Med, 344, 495, 10.1056/NEJM200102153440706 · DOI · Paper page
  10. Bedossa, 2003, Sampling variability of liver fibrosis in chronic hepatitis C, Hepatology, 38, 1449, 10.1016/j.hep.2003.09.022 · DOI · Paper page
  11. Colloredo, 2003, Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease, J Hepatol, 39, 239, 10.1016/S0168-8278(03)00191-0 · DOI · Paper page
  12. Maharaj, 1986, Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver, Lancet, 1, 523, 10.1016/S0140-6736(86)90883-4 · DOI · Paper page
  13. Halfon, 2008, FibroTest-ActiTest as a non-invasive marker of liver fibrosis, Gastroenterol Clin Biol, 32, 22, 10.1016/S0399-8320(08)73991-5 · DOI
  14. de Ledinghen, 2008, Transient elastography (FibroScan), Gastroenterol Clin Biol, 32, 58, 10.1016/S0399-8320(08)73994-0 · DOI · Paper page
  15. de Ledinghen, 2006, Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients, J Acquir Immune Defic Syndr, 41, 175, 10.1097/01.qai.0000194238.15831.c7 · DOI · Paper page
  16. Marcellin, 2009, Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B, Liver Int, 29, 242, 10.1111/j.1478-3231.2008.01802.x · DOI · Paper page
  17. Ziol, 2005, Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C, Hepatology, 41, 48, 10.1002/hep.20506 · DOI · Paper page
  18. Laharie, 2006, Diagnosis of liver fibrosis by transient elastography (FibroScan) and non-invasive methods in Crohn’s disease patients treated with methotrexate, Aliment Pharmacol Ther, 23, 1621, 10.1111/j.1365-2036.2006.02929.x · DOI
  19. Berends, 2007, Biochemical and biophysical assessment of MTX-induced liver fibrosis in psoriasis patients: FibroTest predicts the presence and FibroScan predicts the absence of significant liver fibrosis, Liver Int, 27, 639, 10.1111/j.1478-3231.2007.01489.x · DOI
  20. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486–2497. · DOI · Paper page
  21. Imbert-Bismut, 2001, Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study, Lancet, 357, 1069, 10.1016/S0140-6736(00)04258-6 · DOI · Paper page
  22. Fleming, 2008, Incidence and prevalence of cirrhosis in the United Kingdom, 1992–2001: a general population-based study, J Hepatol, 49, 732, 10.1016/j.jhep.2008.05.023 · DOI · Paper page
  23. Fisher, 2009, Metaanalysis of methylenetetrahydrofolate reductase (MTHFR) polymorphisms affecting methotrexate toxicity, J Rheumatol, 36, 539, 10.3899/jrheum.080576 · DOI
  24. Zachariae, 2000, Liver biopsies and methotrexate: a time for reconsideration?, J Am Acad Dermatol, 42, 531, 10.1016/S0190-9622(00)90237-8 · DOI
  25. Robinson, 1980, Methotrexate hepatotoxicity in psoriasis. Consideration of liver biopsies at regular intervals, Arch Dermatol, 116, 413, 10.1001/archderm.1980.01640280049016 · DOI
  26. Newman, 1989, The role of liver biopsies in psoriatic patients receiving long-term methotrexate treatment. Improvement in liver abnormalities after cessation of treatment, Arch Dermatol, 125, 1218, 10.1001/archderm.1989.01670210056007 · DOI
  27. Roenigk, 1998, Methotrexate in psoriasis: consensus conference, J Am Acad Dermatol, 38, 478, 10.1016/S0190-9622(98)70508-0 · DOI · Paper page
  28. Aithal, 2004, Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified?, Aliment Pharmacol Ther, 19, 391, 10.1046/j.1365-2036.2004.01819.x · DOI
  29. Pavy, 2006, Methotrexate therapy for rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion, Joint Bone Spine, 73, 388, 10.1016/j.jbspin.2006.01.007 · doi:10.1016/j.jbspin.2006.01.007
  30. Lambert, 2004, Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial, Arthritis Rheum, 50, 364, 10.1002/art.20167 · doi:10.1002/art.20167
  31. Bridges, 1989, Methotrexate-induced liver abnormalities in rheumatoid arthritis, J Rheumatol, 16, 1180
  32. Whiting-O’Keefe, 1991, Methotrexate and histologic hepatic abnormalities: a meta-analysis, Am J Med, 90, 711, 10.1016/S0002-9343(05)80060-9 · DOI · Paper page
  33. Herron, 2005, Impact of obesity and smoking on psoriasis presentation and management, Arch Dermatol, 141, 1527, 10.1001/archderm.141.12.1527 · DOI · Paper page
  34. Gisondi, 2009, Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis, J Hepatol, 51, 758, 10.1016/j.jhep.2009.04.020 · DOI · Paper page
  35. Rosenberg, 2007, Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment, J Hepatol, 46, 1111, 10.1016/j.jhep.2007.01.024 · DOI · Paper page
  36. Regev, 2002, Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection, Am J Gastroenterol, 97, 2614, 10.1111/j.1572-0241.2002.06038.x · doi:10.1111/j.1572-0241.2002.06038.x · Paper page
  37. Siddique, 2003, Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection, Scand J Gastroenterol, 38, 427, 10.1080/00365520310000825 · DOI · Paper page
  38. Poynard, 2007, Meta-analyses of FibroTest diagnostic value in chronic liver disease, BMC Gastroenterol, 7, 40, 10.1186/1471-230X-7-40 · DOI · Paper page
  39. Amital, 2009, Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate, Rheumatology, 48, 1107, 10.1093/rheumatology/kep176 · doi:10.1093/rheumatology/kep176
  40. Wahed, 2009, Efficacy of methotrexate in Crohn’s disease and ulcerative colitis patients unresponsive or intolerant to azathioprine/mercaptopurine, Aliment Pharmacol Ther, 30, 614, 10.1111/j.1365-2036.2009.04073.x · DOI
  41. Van Dooren-Greebe, 1994, Methotrexate revisited: effects of long-term treatment in psoriasis, Br J Dermatol, 130, 204, 10.1111/j.1365-2133.1994.tb02901.x · doi:10.1111/j.1365-2133.1994.tb02901.x
  42. van Ede, 2001, Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study, Arthritis Rheum, 44, 1515, 10.1002/1529-0131(200107)44:7<1515::AID-ART273>3.0.CO;2-7 · DOI · Paper page
  43. Lindsay, 2009, Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy, Rheumatology (Oxford), 48, 569, 10.1093/rheumatology/kep023 · DOI
  44. Visser, 2009, Ann Rheum Dis, 68, 1086, 10.1136/ard.2008.094474 · DOI · Paper page

Cited by

See all 92

Metadata

Authors
Laharie, D., Seneschal, J., Schaeverbeke, T., Doutre, M.-S., Longy-Boursier, M., Pellegrin, J.-L., Chabrun, E., Villars, S., Zerbib, F., & de Lédinghen, V.
Venue
Journal of Hepatology
Publisher
Elsevier BV
Published
2010-12
Volume
53
Issue
6
Pages
1035-1040
ISSN
0168-8278
Cited by
92
References
3
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Assessment of liver fibrosis with transient elastography and FibroTest in patients treated with methotrexate for chronic inflammatory diseases: A case–control study. https://app.cochat.ai/papers/10.1016/j.jhep.2010.04.043
The paper
Laharie, D., Seneschal, J., Schaeverbeke, T., Doutre, M.-S., Longy-Boursier, M., Pellegrin, J.-L., Chabrun, E., Villars, S., Zerbib, F., & de Lédinghen, V. (2010). Assessment of liver fibrosis with transient elastography and FibroTest in patients treated with methotrexate for chronic inflammatory diseases: A case–control study. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2010.04.043

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.